WELL Health Technologies Corp. (TSX:WELL)
Canada · Delayed Price · Currency is CAD 4.380
+0.040 (0.92%)
Aug 26, 2026, 4:00 PM EST
WELL Health Technologies Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,518 | 1,400 | 919.69 | 776.05 | 569.14 | 302.32 | |
Revenue Growth | 35.58% | 52.24% | 18.51% | 36.36% | 88.25% | 501.76% |
Cost of Revenue | 833.85 | 781.34 | 556.68 | 403.79 | 265.85 | 148.63 |
Gross Profit | 684.21 | 618.84 | 363.01 | 372.27 | 303.29 | 153.7 |
Selling, General & Admin | 460.89 | 408.8 | 305.3 | 250.82 | 190.52 | 92.52 |
Operating Expenses | 591.08 | 525.25 | 392.88 | 337.75 | 270.21 | 152.24 |
Operating Income | 93.13 | 93.59 | -29.86 | 34.52 | 33.08 | 1.46 |
Interest Expense | -76.25 | -57.88 | -37.62 | -33.6 | -25.29 | -9.01 |
Interest & Investment Income | 1.72 | 1.72 | 1.27 | 0.76 | 0.65 | 0.56 |
Earnings From Equity Investments | -0.54 | -2.75 | -4.34 | -0.38 | -0.4 | -0.21 |
Currency Exchange Gain (Loss) | -3.12 | -2.61 | 0.57 | 0.64 | -0.67 | -4.75 |
Other Non Operating Income (Expenses) | 1.82 | -1.06 | -5.54 | -5.16 | -2 | 1.55 |
EBT Excluding Unusual Items | 16.75 | 31 | -75.51 | -3.22 | 5.37 | -10.41 |
Merger & Restructuring Charges | -6.48 | - | - | - | -2.49 | -9.99 |
Gain (Loss) on Sale of Investments | 18.45 | -21.71 | 101.48 | 42.56 | 0.28 | - |
Gain (Loss) on Sale of Assets | 11.43 | 11.36 | 11.82 | 1.57 | 5.21 | - |
Asset Writedown | -11.61 | -11.61 | - | - | - | - |
Legal Settlements | -11.86 | -2.63 | -21.34 | - | - | - |
Other Unusual Items | -4.57 | -7.8 | -7.46 | -21.41 | 9.16 | -5.09 |
Pretax Income | 18.81 | 5.31 | 8.99 | 19.5 | 17.53 | -25.49 |
Income Tax Expense | 2.58 | 0.85 | -20.1 | 2.86 | -1.15 | 5.8 |
Earnings From Continuing Operations | 16.23 | 4.46 | 29.1 | 16.64 | 18.68 | -31.29 |
Net Income to Company | 16.23 | 4.46 | 29.1 | 16.64 | 18.68 | -31.29 |
Minority Interest in Earnings | -12.47 | -11.82 | 3.51 | -16.56 | -17.31 | -12.89 |
Net Income | 3.77 | -7.36 | 32.61 | 0.08 | 1.37 | -44.18 |
Net Income to Common | 3.77 | -7.36 | 32.61 | 0.08 | 1.37 | -44.18 |
Net Income Growth | - | - | 39667.07% | -94.01% | - | - |
Shares Outstanding (Basic) | 254 | 253 | 247 | 237 | 221 | 191 |
Shares Outstanding (Diluted) | 254 | 253 | 255 | 237 | 221 | 191 |
Shares Change | 1.64% | -0.73% | 7.66% | 7.18% | 15.61% | 42.56% |
EPS (Basic) | 0.01 | -0.03 | 0.13 | 0.00 | 0.01 | -0.23 |
EPS (Diluted) | 0.01 | -0.03 | 0.13 | 0.00 | 0.01 | -0.23 |
EPS Growth | - | - | 37471.96% | -94.42% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 82.83 | 81.74 | -17 | 41.05 | 69.93 | -30.21 |
Free Cash Flow Per Share | 0.33 | 0.32 | -0.07 | 0.17 | 0.32 | -0.16 |
Gross Margin | 45.07% | 44.20% | 39.47% | 47.97% | 53.29% | 50.84% |
Operating Margin | 6.13% | 6.68% | -3.25% | 4.45% | 5.81% | 0.48% |
Profit Margin | 0.25% | -0.53% | 3.55% | 0.01% | 0.24% | -14.61% |
Free Cash Flow Margin | 5.46% | 5.84% | -1.85% | 5.29% | 12.29% | -9.99% |
EBITDA | 174.53 | 166.69 | 26.11 | 84.74 | 80.22 | 35.27 |
EBITDA Margin | 11.50% | 11.91% | 2.84% | 10.92% | 14.09% | 11.67% |
D&A For EBITDA | 81.4 | 73.1 | 55.98 | 50.22 | 47.13 | 33.81 |
EBIT | 93.13 | 93.59 | -29.86 | 34.52 | 33.08 | 1.46 |
EBIT Margin | 6.13% | 6.68% | -3.25% | 4.45% | 5.81% | 0.48% |
Effective Tax Rate | 13.71% | 15.94% | - | 14.67% | - | - |